Medistim ASA
OSE:MEDI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medistim ASA
OSE:MEDI
|
NO |
|
A
|
AGBA Acquisition Ltd
NASDAQ:AGBA
|
HK |
|
Astrindo Nusantara Infrastruktur Tbk PT
IDX:BIPI
|
ID |
|
Macatawa Bank Corp
NASDAQ:MCBC
|
US |
|
D
|
Dan Hotels Ltd
TASE:DANH
|
IL |
|
A2B Australia Ltd
ASX:A2B
|
AU |
|
M
|
Michang Oil Ind Co Ltd
KRX:003650
|
KR |
Wall Street
Price Targets
MEDI Price Targets Summary
Medistim ASA
According to Wall Street analysts, the average 1-year price target for
MEDI
is 316.2 NOK
with a low forecast of 313.1 NOK and a high forecast of 325.5 NOK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MEDI's stock price target?
Price Target
316.2
NOK
According to Wall Street analysts, the average 1-year price target for
MEDI
is 316.2 NOK
with a low forecast of 313.1 NOK and a high forecast of 325.5 NOK.
What is Medistim ASA's Revenue forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Medistim ASA's revenue is
11%.
The projected
CAGR
for the next 3 years is
9%.
What is Medistim ASA's Operating Income forecast?
Projected CAGR
8%
For the last 14 years the
compound annual growth rate for
Medistim ASA's operating income is
16%.
The projected
CAGR
for the next 3 years is
8%.
What is Medistim ASA's Net Income forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
Medistim ASA's net income is
18%.
The projected
CAGR
for the next 3 years is
10%.
